Key Cutaneous Radiation Injury Treatment Market Players:
- Amgen Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sanofi
- Novartis AG
- Pfizer Inc.
- Mallinckrodt plc
- Bayer AG
- Mylan N.V. (part of Viatris)
- Teva Pharmaceutical Industries Ltd.
- Rakuten Medical, Inc.
- Humanigen, Inc.
- Partner Therapeutics, Inc.
- Shield Therapeutics PLC
- Celltrion Inc.
- Daiichi Sankyo Company, Limited
- CSL Limited
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- Hikma Pharmaceuticals PLC
- Biogen Inc.
- Duopharma Biotech Berhad
The cutaneous radiation injury treatment market is extensively concentrated, with the leading pioneers, 3M, Smith & Nephew, Amgen, Mölnlycke, and ConvaTec controlling the maximum revenue share. These players undertake numerous strategies to secure their market positions, such as production differentiation emphasized by 3M, Smith & Nephew with the FDA and CE-approved dressings. In addition, the biologic expansion is at a boom with Amgen’s Kineret targeting severe CRI to gain more sales by the end of 2026. Furthermore, the emerging firms such as PolyNovo and Toray are readily investing in nanotech dressings for radiation burns.
Top players in this landscape are listed below:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of the cutaneous radiation injury treatment market was over USD 554.3 million.
The market size for the cutaneous radiation injury treatment market is projected to reach USD 1545.6 million by the end of 2035, expanding at a CAGR of 10.8% during the forecast period, i.e., between 2026-2035.
The major players in the market are Amgen Inc., Sanofi, Novartis AG, Pfizer Inc., Mallinckrodt plc, and others.
In terms of the distribution channel segment, the government stockpiles & direct procurement segment is anticipated to garner the largest market share of 80.3% by 2035 and display lucrative growth opportunities during 2026-2035.
The market in North America is projected to hold the largest market share of 38.5% by the end of 2035 and provide more business opportunities in the future.
